更正：杜普伊特伦挛缩复发：基于共识的定义。
Correction: Recurrence of Dupuytren's contracture: A consensus-based definition.
作者信息
Kan Hester J, Verrijp Frank W, Hovius Steven E R, van Nieuwenhoven Christianne A, Selles Ruud W
出版信息
PLoS One. 2019 Apr 25;14(4):e0216313. doi: 10.1371/journal.pone.0216313. eCollection 2019.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0164849.].
摘要
[本文更正了文章的数字对象标识符：10.1371/journal.pone.0164849。]
相似文献
1
Correction: Recurrence of Dupuytren's contracture: A consensus-based definition.更正：杜普伊特伦挛缩复发：基于共识的定义。
PLoS One. 2019 Apr 25;14(4):e0216313. doi: 10.1371/journal.pone.0216313. eCollection 2019.
2
Results of surgical treatment of Dupuytren's disease in women: a review of 109 consecutive patients.女性掌腱膜挛缩症的外科治疗结果：109例连续患者的回顾
J Hand Surg Am. 2007 Nov;32(9):1423-8. doi: 10.1016/j.jhsa.2007.06.015.
3
Recurrence of Dupuytren's contracture: A consensus-based definition.掌腱膜挛缩症的复发：基于共识的定义。
PLoS One. 2017 May 15;12(5):e0164849. doi: 10.1371/journal.pone.0164849. eCollection 2017.
4
Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique.采用增加剂量的多索技术，通过胶原酶注射治疗144例掌腱膜挛缩症患者的连续系列早期结果。
J Hand Surg Eur Vol. 2015 Feb;40(2):133-40. doi: 10.1177/1753193414530590. Epub 2014 Apr 2.
5
Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.掌腱膜挛缩症管理的成本效益。加拿大当前和未来管理策略的成本效益分析。
Bone Joint J. 2013 Aug;95-B(8):1094-100. doi: 10.1302/0301-620X.95B8.31822.
6
[Collagenase Clostridum histolyticum in the management of Dupuytren's contracture].[溶组织梭菌胶原酶在掌腱膜挛缩症治疗中的应用]
Handchir Mikrochir Plast Chir. 2011 Oct;43(5):269-74. doi: 10.1055/s-0031-1286314. Epub 2011 Sep 20.
7
Comparison of palmar aponeuroses from individuals with diabetes mellitus and Dupuytren's contracture.糖尿病患者与掌腱膜挛缩症患者掌腱膜的比较。
Anat Rec. 1999 Aug 1;255(4):401-6. doi: 10.1002/(SICI)1097-0185(19990801)255:4<401::AID-AR6>3.0.CO;2-D.
8
An insight into Dupuytren's contracture.深入了解杜普伊特伦挛缩症。
Ann R Coll Surg Engl. 1992 May;74(3):156-60; discussion 161.
9
Free radicals and Dupuytren's contracture.自由基与掌腱膜挛缩症
Br Med J (Clin Res Ed). 1987 Nov 28;295(6610):1373-5. doi: 10.1136/bmj.295.6610.1373.
10
'Firebreak' grafts in Dupuytren's contracture.杜普伊特伦挛缩症中的“防火带”移植术
Aust N Z J Surg. 1984 Jun;54(3):277-81. doi: 10.1111/j.1445-2197.1984.tb05317.x.
引用本文的文献
1
Limited fasciectomy with versus without autologous adipose tissue grafting for treatment of Dupuytren's contracture (REMEDY): study protocol for a multicentre randomised controlled trial.局限性掌腱膜切除术联合与不联合自体脂肪组织移植治疗掌腱膜挛缩症（REMEDY）：一项多中心随机对照试验的研究方案。
Trials. 2024 Sep 2;25(1):577. doi: 10.1186/s13063-024-08410-4.
本文引用的文献
1
Recurrence of Dupuytren's contracture: A consensus-based definition.掌腱膜挛缩症的复发：基于共识的定义。
PLoS One. 2017 May 15;12(5):e0164849. doi: 10.1371/journal.pone.0164849. eCollection 2017.
2
Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence.杜普伊特伦挛缩复发项目：就复发的定义达成共识。
Handchir Mikrochir Plast Chir. 2014 Dec;46(6):350-4. doi: 10.1055/s-0034-1394420. Epub 2014 Nov 20.
3
Patterns of recontracture after surgical correction of Dupuytren disease.Dupuytren病手术矫正后的再挛缩模式。
J Hand Surg Am. 2013 Oct;38(10):1987-93. doi: 10.1016/j.jhsa.2013.05.038. Epub 2013 Jul 30.
4
The consequences of different definitions for recurrence of Dupuytren's disease.不同的掌腱膜挛缩症复发定义的后果。
J Plast Reconstr Aesthet Surg. 2013 Jan;66(1):95-103. doi: 10.1016/j.bjps.2012.08.019. Epub 2012 Nov 6.
5
Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.一项关于掌腱膜挛缩病治疗的随机临床试验的 5 年结果：经皮针刀松解与有限筋膜切开术。
Plast Reconstr Surg. 2012 Feb;129(2):469-477. doi: 10.1097/PRS.0b013e31823aea95.
Zotero 插件